301
Participants
Start Date
April 24, 2018
Primary Completion Date
July 31, 2024
Study Completion Date
December 31, 2024
RC48-ADC
RC48-ADC 2.0 mg/kg IV every 14 days
Lapatinib
Lapatinib 1250 mg orally once daily during each 21-day cycle.
Capecitabine
Capecitabine 2000 mg/m\^2 orally daily on Days 1-14 of each 21-day treatment cycle.
Cancer Hospital Chinese Academy of Medical Sciences, Beijing
Liaoning Cancer Hospital & Institute, Shenyang
The First Hospital of China Medical University, Shenyang
An Yang Cancer Hospital, Anyang
Beijing Luhe Hospital, Beijing
Peking University People's Hospital, Beijing
The First Affiliated Hospital of Bengbu Medical College, Bengbu
Bin Zhou No.1 People's Hospital, Binzhou
Jilin Cancer Hospital, Changchun
The First Hospital Jilin University, Changchun
The First Hospital of Jilin University, Changchun
Hunan Cancer Hospital, Changsha
The Second Xiyang Hospital of Central South University, Changsha
Xiangya Hospital Central South University, Changsha
Heping Hospital Affiliated to Changzhi Medical College, Changzhi
Affiliated Hospital of Chengde Medical University, Chengde
West China Hospital,Sichuan University, Chengdu
Chongqing University Three gorges Hospital, Chongqing
The Southwest Hospital of AMU, Chongqing
The Second Hospital of Dalian Medical University, Dalian
Fujian Cancer Hospital, Fuzhou
Guangdong Provincial People's Hospital, Guangzhou
Sun Yat-Sen Memorial Hospital, Guangzhou
The Affiliated Tumor Hospital of Guangzhou Medical University, Guangzhou
Guizhou Cancer Hospital, Guiyang
The First Affiliated Hospital of Medical School of Zhejiang University, Hangzhou
The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou
Zhejiang Cancer Hospital, Hangzhou
Harbin Medical University Cancer Hospital, Ha’erbin
Anhui Cancer Hospital, Hefei
Anhui Province Hospital, Hefei
The First Affiliated Hospital of Anhui Medical University, Hefei
Qilu Hospital of Shandong University, Jinan
The First People's Hospital of Jining, Jining
Yunnan Cancer Hospital, Kunming
Linyi Cancer Hospital, Linyi
The First Affiliated Hospital of Henan University of Science & Technology, Luoyang
Jiangsu Cancer Hospital, Nanjing
The Affiliated Tumor Hospital of Guangxi Medical University, Nanning
The Second People's Hospital of Neijiang, Neijiang
Hospital of Qingdao University, Qingdao
Fudan University Shanghai Cancer Center, Shanghai
Shanghai Changhai Hospital, Shanghai
Shanghai Ruijin Hospital, Shanghai
Cancer Hospital of Shantou University Medical College, Shantou
Yue Bei People's Hospital, Shaoguan
The Fourth Hospital of Hebei Medical University, Shijiazhuang
Shanxi Bethune Hospital, Taiyuan
Shanxi Cancer Hospital, Taiyuan
Taizhou Enze Medical Center, Taizhou
Tai'an City Central Hospital, Tai’an
Tianjin Cancer Hospitial, Tianjin
Weihai Municipal Hospital, Weihai
Hubei Cancer Hospital, Wuhan
Tongji Medical College of HUST, Wuhan
Wuhan Union Hospital, Wuhan
The First Affiliated Hospital of the Fourth Military University of P.L.A., Xi'an
The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an
Xing Tai People's Hospital, Xingtai
The First Affiliated Hospital of Xinxiang Medical University, Xinxiang
The Affiliated Hospital of Xuzhou Medical University, Xuzhou
Xuzhou Central Hospital, Xuzhou
Yanbian University Hospital, Yanbian
Yantai Yuhuangding Hospital, Yantai
Yuncheng Central Hospital, Yuncheng
Henan Cancer Hospital, Zhengzhou
The First Affiliated Hospital of Zhengzhou University, Zhengzhou
RemeGen Co., Ltd.
INDUSTRY